Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU
Clinical trial NCT02998996 · COMPLETED
Trial details
- NCT number
- NCT02998996
- Sponsor
- Eurocine Vaccines AB
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2017-06-01
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.